CHARLES ANDERSON
- Type
- Physician · Allopathic & Osteopathic Physicians / Obstetrics & Gynecology
- Where
- SWEETWATER, TX
- NPI
- 1720197635
- Received
- $1,160 in 77 records, 2019 to 2025
- As principal investigator
- $18,035 of research payments to others in 8 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 2 | $43 |
| 2024 | General payment | 3 | $53 |
| 2023 | General payment | 10 | $188 |
| 2022 | General payment | 23 | $266 |
| 2021 | General payment | 21 | $218 |
| 2020 | General payment | 12 | $250 |
| 2019 | General payment | 6 | $139 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| ABBVIE INC. | 45 | $499 | 2019–2025 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $75 | 2023 |
| Acessa Health Inc. | 1 | $69 | 2020 |
| Acessa Health Inc. | 2 | $68 | 2021 |
| Minerva Surgical, Inc | 1 | $59 | 2019 |
| PFIZER INC. | 3 | $45 | 2019–2021 |
| TherapeuticsMD, Inc. | 3 | $43 | 2020–2021 |
| Allergan, Inc. | 2 | $37 | 2020 |
| Lupin Inc. | 2 | $34 | 2019 |
| Exeltis, USA Inc. | 2 | $34 | 2022–2023 |
| Astellas Pharma US Inc | 2 | $32 | 2023–2024 |
| Eisai Inc. | 2 | $32 | 2020 |
| Lilly USA, LLC | 2 | $29 | 2020 |
| Organon Llc | 2 | $23 | 2022 |
| Merck Sharp & Dohme LLC | 1 | $20 | 2020 |
| Biogen, Inc. | 1 | $19 | 2025 |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | 1 | $17 | 2022 |
| Evofem Biosciences, Inc. | 1 | $17 | 2022 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Food and Beverage | 77 | $1,160 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-10-14 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-04-17 | Biogen, Inc. | $19 | Food and Beverage | In-kind items and services | ZURZUVAE Drug, Neurology | 2025 | |
| 2024-04-16 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | LO LOESTRIN FE Drug, WOMENS HEALTH | 2024 | |
| 2024-03-01 | Astellas Pharma US Inc | $13 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2024 | |
| 2024-02-27 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2024 | |
| 2023-12-19 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | LILETTA Drug, WOMENS HEALTH | 2023 | |
| 2023-12-07 | MAYNE PHARMA COMMERCIAL LLC | $23 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-07-26 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | LILETTA Drug, WOMENS HEALTH | 2023 | |
| 2023-07-10 | Astellas Pharma US Inc | $19 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2023 | |
| 2023-05-08 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2023 | |
| 2023-04-18 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2023 | |
| 2023-04-03 | MAYNE PHARMA COMMERCIAL LLC | $18 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-03-22 | Exeltis, USA Inc. | $18 | Food and Beverage | In-kind items and services | SLYND Drug, Oral Contraceptive | 2023 | |
| 2023-02-23 | MAYNE PHARMA COMMERCIAL LLC | $10 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-02-22 | MAYNE PHARMA COMMERCIAL LLC | $22 | Food and Beverage | In-kind items and services | 2023 | ||
| 2022-12-12 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2022 | |
| 2022-11-17 | ABBVIE INC. | $1 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2022 | |
| 2022-10-24 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2022 | |
| 2022-10-12 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2022 | |
| 2022-10-11 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2022 | |
| 2022-08-31 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2022 | |
| 2022-08-24 | Evofem Biosciences, Inc. | $17 | Food and Beverage | In-kind items and services | Phexxi Drug, Miscellaneous vaginal agent | 2022 | |
| 2022-08-19 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2022 | |
| 2022-08-02 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2022 | |
| 2022-07-13 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2022 | |
| 2022-06-28 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2022 | |
| 2022-06-21 | Organon Llc | $16 | Food and Beverage | In-kind items and services | NEXPLANON Drug, ETONOGESTREL | 2022 | |
| 2022-06-16 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | LILETTA Drug, WOMENS HEALTH | 2022 | |
| 2022-05-31 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2022 | |
| 2022-05-18 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2022 | |
| 2022-05-16 | Exeltis, USA Inc. | $15 | Food and Beverage | In-kind items and services | SLYND Drug, Oral Contraceptive | 2022 | |
| 2022-05-09 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2022 | |
| 2022-05-03 | Organon Llc | $7 | Food and Beverage | In-kind items and services | NEXPLANON Drug, ETONOGESTREL | 2022 | |
| 2022-03-29 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2022 | |
| 2022-02-25 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2022 | |
| 2022-01-12 | ABBVIE INC. | $71 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2022 | |
| 2022-01-12 | BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | $17 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PRIMARY CARE | 2022 | |
| 2022-01-06 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2022 | |
| 2021-12-21 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-12-17 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2021 | |
| 2021-12-15 | PFIZER INC. | $13 | Food and Beverage | In-kind items and services | PREMARIN Drug, WOMENS HEALTH | 2021 | |
| 2021-10-13 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2021 | |
| 2021-09-16 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-08-31 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | LO LOESTRIN FE Drug, WOMENS HEALTH | 2021 | |
| 2021-06-29 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-06-29 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-06-16 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-05-25 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-05-18 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-04-28 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-04-08 | TherapeuticsMD, Inc. | $13 | Food and Beverage | In-kind items and services | ANNOVERA Drug, OBSTETRICS GYNECOLOGY WOMEN'S HEALTH | 2021 | |
| 2021-04-07 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-03-17 | Acessa Health Inc. | $53 | Food and Beverage | In-kind items and services | ACESSA PROVU SYSTEM Device, Surgical | 2021 | |
| 2021-03-17 | Acessa Health Inc. | $15 | Food and Beverage | In-kind items and services | ACESSA PROVU SYSTEM Device, Surgical | 2021 | |
| 2021-03-16 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-03-16 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-02-23 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-01-28 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2021-01-19 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2021 | |
| 2020-12-23 | Allergan, Inc. | $19 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2020 | |
| 2020-12-09 | Eisai Inc. | $16 | Food and Beverage | Cash or cash equivalent | Dayvigo Drug, Neurology | 2020 | |
| 2020-11-03 | TherapeuticsMD, Inc. | $16 | Food and Beverage | In-kind items and services | ANNOVERA Drug, OBSTETRICSGYNECOLOGY WOMEN'S HEALTH | 2020 | |
| 2020-10-06 | Eisai Inc. | $15 | Food and Beverage | Cash or cash equivalent | Dayvigo Drug, Neurology | 2020 | |
| 2020-09-23 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | LO LOESTRIN FE Drug, WOMENS HEALTH | 2020 | |
| 2020-09-16 | Lilly USA, LLC | $12 | Food and Beverage | In-kind items and services | REYVOW Drug, Neuroscience | 2020 | |
| 2020-09-02 | Merck Sharp & Dohme LLC | $20 | Food and Beverage | In-kind items and services | NEXPLANON Drug, WOMENS HEALTH | 2020 | |
| 2020-07-29 | PFIZER INC. | $14 | Food and Beverage | In-kind items and services | PREMARIN Drug, WOMENS HEALTH | 2020 | |
| 2020-07-23 | Allergan, Inc. | $17 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2020 | |
| 2020-07-21 | Lilly USA, LLC | $16 | Food and Beverage | In-kind items and services | REYVOW Drug, Neuroscience | 2020 | |
| 2020-06-24 | TherapeuticsMD, Inc. | $13 | Food and Beverage | In-kind items and services | ANNOVERA Drug, OBSTETRICSGYNECOLOGY WOMEN'S HEALTH | 2020 | |
| 2020-06-04 | Acessa Health Inc. | $69 | Food and Beverage | In-kind items and services | Acessa Drug, Gynecology | 2020 | |
| 2019-10-24 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | Orilissa Drug, Endocrinology | 2019 | |
| 2019-09-26 | PFIZER INC. | $18 | Food and Beverage | In-kind items and services | PREMARIN Drug, WOMENS HEALTH | 2019 | |
| 2019-09-04 | Lupin Inc. | $12 | Food and Beverage | In-kind items and services | SOLOSEC Drug, OBSTETRICSGYNECOLOGY | 2019 | |
| 2019-03-21 | Lupin Inc. | $21 | Food and Beverage | In-kind items and services | SOLOSEC Drug, OBSTETRICSGYNECOLOGY | 2019 | |
| 2019-03-20 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | Orilissa Drug, Endocrinology | 2019 | |
| 2019-03-19 | Minerva Surgical, Inc | $59 | Food and Beverage | In-kind items and services | Endometrial Ablation System (Device) Device, Product (surgical device) | 2019 |
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2023-10-30 | Karyopharm Therapeutics Inc. | ONCOLOGY ASSOCIATES OF OREGON | $2,303 | A Randomized, Double-Blind, Phase 3 Trial of Maintenance with Selinexor/Placebo After Combination Chemotherapy for Patie | 2023 |
| 2023-09-19 | Karyopharm Therapeutics Inc. | ONCOLOGY ASSOCIATES OF OREGON | $2,303 | A Randomized, Double-Blind, Phase 3 Trial of Maintenance with Selinexor/Placebo After Combination Chemotherapy for Patie | 2023 |
| 2023-09-07 | Karyopharm Therapeutics Inc. | ONCOLOGY ASSOCIATES OF OREGON | $4,862 | A Randomized, Double-Blind, Phase 3 Trial of Maintenance with Selinexor/Placebo After Combination Chemotherapy for Patie | 2023 |
| 2023-03-09 | Karyopharm Therapeutics Inc. | ONCOLOGY ASSOCIATES OF OREGON | $4,868 | A Randomized, Double-Blind, Phase 3 Trial of Maintenance with Selinexor/Placebo After Combination Chemotherapy for Patie | 2023 |
| 2022-05-26 | Karyopharm Therapeutics Inc. | ONCOLOGY ASSOCIATES OF OREGON | $2,559 | A Randomized, Double-Blind, Phase 3 Trial of Maintenance with Selinexor/Placebo After Combination Chemotherapy for Patie | 2022 |
| 2022-02-17 | Karyopharm Therapeutics Inc. | ONCOLOGY ASSOCIATES OF OREGON | $637 | A Randomized, Double-Blind, Phase 3 Trial of Maintenance with Selinexor/Placebo After Combination Chemotherapy for Patie | 2022 |
| 2022-02-07 | Karyopharm Therapeutics Inc. | ONCOLOGY ASSOCIATES OF OREGON | $250 | A Randomized, Double-Blind, Phase 3 Trial of Maintenance with Selinexor/Placebo After Combination Chemotherapy for Patie | 2022 |
| 2022-01-12 | Karyopharm Therapeutics Inc. | ONCOLOGY ASSOCIATES OF OREGON | $250 | A Randomized, Double-Blind, Phase 3 Trial of Maintenance with Selinexor/Placebo After Combination Chemotherapy for Patie | 2022 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Sweetwater, TX, county Nolan County, TX, state Texas; placed by its city name.
| Measure | Place (city or town) Sweetwater, TX | County Nolan County, TX | State Texas |
|---|---|---|---|
| Population B01003 | 10,385 | 14,454 | 30,188,424 |
| Population, 2020 census P1 | 10,622 | 14,738 | 29,145,505 |
| Median age B01002 | 37.1 | 39.3 | 35.6 |
| Under 18 B01001 | 27.3% | 25.4% | 25.0% |
| 65 and over B01001 | 17.5% | 19.5% | 13.4% |
| Households B11001 | 4,245 | 5,886 | 10,992,816 |
| Foreign born B05002 | 4.6% | 4.5% | 17.6% |
| Median household income B19013 | $44,892 | $50,747 | $78,476 |
| Median family income B19113 | $51,011 | $61,551 | $94,599 |
| Per capita income B19301 | $26,860 | $32,182 | $40,752 |
| Poverty rate B17001 | 28.1% | 22.5% | 13.8% |
| Unemployment rate B23025 | 6.9% | 6.0% | 5.3% |
| Civilian labor force B23025 | 4,786 | 6,684 | 15,233,563 |
| Mean commute (minutes) B08013 | 16.1 | 18.3 | 26.7 |
| Bachelor's degree or higher B15003 | 14.1% | 16.0% | 33.8% |
| Housing units B25001 | 5,170 | 7,104 | 12,128,515 |
| Owner-occupied B25003 | 59.7% | 68.1% | 62.6% |
| Renters B25003 | 40.3% | 31.9% | 37.4% |
| Median home value B25077 | $80,800 | $96,300 | $283,800 |
| Median gross rent B25064 | $907 | $913 | $1,403 |
| White, not Hispanic B03002 | 49.0% | 53.8% | 39.1% |
| Black B03002 | 2.5% | 2.7% | 11.9% |
| Hispanic or Latino B03002 | 42.8% | 37.4% | 39.7% |
| Asian B03002 | 0.0% | 0.1% | 5.5% |
| American Indian and Alaska Native B03002 | 0.7% | 0.7% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Sweetwater, TX.
Comments